Jing Wei1, Nicholas M Graziane1, Haitao Wang1, Ping Zhong1, Qi Wang2, Wenhua Liu1, Akiko Hayashi-Takagi3, Carsten Korth4, Akira Sawa3, Nicholas J Brandon2, Zhen Yan1. 1. Department of Physiology and Biophysics, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, NY, USA. 2. Pfizer Neuroscience Research Unit, Cambridge, MA, USA. 3. Dept. of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 4. Dept. of Neuropathology, University of Düsseldorf Medical School, Germany.
Abstract
BACKGROUND: Genetic studies have implicated disrupted-in-schizophrenia-1 (DISC1) as a risk factor for a wide range of mental conditions, including schizophrenia. Because N-methyl-D-aspartate receptor (NMDAR) dysfunction has been strongly linked to the pathophysiology of these conditions, we examined whether the NMDAR is a potential target of DISC1. METHODS: DISC1 was knocked down with a small inference RNA. NMDAR-mediated currents were recorded and NMDAR expression was measured. RESULTS: We found that cellular knockdown of DISC1 significantly increased NMDAR currents in cortical cultures, which were accompanied by an increase in the expression of NMDAR subunit, GluN2A. NMDAR-mediated synaptic response in prefrontal cortical pyramidal neurons was also increased by DISC1 knockdown in vivo. The effect of DISC1 knockdown on NMDAR currents in cortical cultures was blocked by protein kinase A (PKA) inhibitor, occluded by PKA activator, and prevented by phosphodiesterase 4 inhibitor. Knockdown of DISC1 caused a significant increase of cyclic adenosine monophosphate response element-binding protein (CREB) activity. Inhibiting CREB prevented the DISC1 deficiency-induced increase of NMDAR currents and GluN2A clusters. CONCLUSIONS: Our results suggest that DISC1 exerts an important impact on NMDAR expression and function through a phosphodiesterase 4/PKA/CREB-dependent mechanism, which provides a potential molecular basis for the role of DISC1 in influencing NMDAR-dependent cognitive and emotional processes.
BACKGROUND: Genetic studies have implicated disrupted-in-schizophrenia-1 (DISC1) as a risk factor for a wide range of mental conditions, including schizophrenia. Because N-methyl-D-aspartate receptor (NMDAR) dysfunction has been strongly linked to the pathophysiology of these conditions, we examined whether the NMDAR is a potential target of DISC1. METHODS:DISC1 was knocked down with a small inference RNA. NMDAR-mediated currents were recorded and NMDAR expression was measured. RESULTS: We found that cellular knockdown of DISC1 significantly increased NMDAR currents in cortical cultures, which were accompanied by an increase in the expression of NMDAR subunit, GluN2A. NMDAR-mediated synaptic response in prefrontal cortical pyramidal neurons was also increased by DISC1 knockdown in vivo. The effect of DISC1 knockdown on NMDAR currents in cortical cultures was blocked by protein kinase A (PKA) inhibitor, occluded by PKA activator, and prevented by phosphodiesterase 4 inhibitor. Knockdown of DISC1 caused a significant increase of cyclic adenosine monophosphate response element-binding protein (CREB) activity. Inhibiting CREB prevented the DISC1deficiency-induced increase of NMDAR currents and GluN2A clusters. CONCLUSIONS: Our results suggest that DISC1 exerts an important impact on NMDAR expression and function through a phosphodiesterase 4/PKA/CREB-dependent mechanism, which provides a potential molecular basis for the role of DISC1 in influencing NMDAR-dependent cognitive and emotional processes.
Authors: Eunice Y Yuen; Wenhua Liu; Ilia N Karatsoreos; Jian Feng; Bruce S McEwen; Zhen Yan Journal: Proc Natl Acad Sci U S A Date: 2009-07-29 Impact factor: 11.205
Authors: Akiko Hayashi-Takagi; Manabu Takaki; Nick Graziane; Saurav Seshadri; Hannah Murdoch; Allan J Dunlop; Yuichi Makino; Anupamaa J Seshadri; Koko Ishizuka; Deepak P Srivastava; Zhong Xie; Jay M Baraban; Miles D Houslay; Toshifumi Tomoda; Nicholas J Brandon; Atsushi Kamiya; Zhen Yan; Peter Penzes; Akira Sawa Journal: Nat Neurosci Date: 2010-02-07 Impact factor: 24.884
Authors: N Sawamura; T Ando; Y Maruyama; M Fujimuro; H Mochizuki; K Honjo; M Shimoda; H Toda; T Sawamura-Yamamoto; L A Makuch; A Hayashi; K Ishizuka; N G Cascella; A Kamiya; N Ishida; T Tomoda; T Hai; K Furukubo-Tokunaga; A Sawa Journal: Mol Psychiatry Date: 2008-09-02 Impact factor: 15.992
Authors: P R Maycox; F Kelly; A Taylor; S Bates; J Reid; R Logendra; M R Barnes; C Larminie; N Jones; M Lennon; C Davies; J J Hagan; C A Scorer; C Angelinetta; M T Akbar; T Akbar; S Hirsch; A M Mortimer; T R E Barnes; J de Belleroche Journal: Mol Psychiatry Date: 2009-03-03 Impact factor: 15.992
Authors: Lynda El-Hassar; Arthur A Simen; Alvaro Duque; Kiran D Patel; Leonard K Kaczmarek; Amy F T Arnsten; Mark F Yeckel Journal: Biol Psychiatry Date: 2014-01-20 Impact factor: 13.382
Authors: Ikwunga Wonodi; Robert P McMahon; Nithin Krishna; Braxton D Mitchell; Judy Liu; Matthew Glassman; L Elliot Hong; James M Gold Journal: Schizophr Res Date: 2014-11-14 Impact factor: 4.939
Authors: Sylwia Fudalej; Andrzej Jakubczyk; Maciej Kopera; Jerzy Piwonski; Wojciech Bielecki; Wojciech Drygas; Krystyna Wasilewska; Mark Ilgen; Amy Bohnert; Kristen Barry; Rafał Płoski; Frederic C Blow; Marcin Wojnar Journal: J Stud Alcohol Drugs Date: 2016-03 Impact factor: 2.582
Authors: Akiko Hayashi-Takagi; Yoichi Araki; Mayumi Nakamura; Benedikt Vollrath; Sergio G Duron; Zhen Yan; Haruo Kasai; Richard L Huganir; David A Campbell; Akira Sawa Journal: Proc Natl Acad Sci U S A Date: 2014-04-03 Impact factor: 11.205